# A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients

> **NCT02996721** · PHASE4 · COMPLETED · sponsor: **Intermountain Health Care, Inc.** · enrollment: 634 (actual)

## Conditions studied

- Death
- Myocardial Infarction
- Cerebral Vascular Accident
- Heart Failure Hospitalization

## Interventions

- **BIOLOGICAL:** Vitamin D3

## Key facts

- **NCT ID:** NCT02996721
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-09-04
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02996721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02996721, "A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02996721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*